Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
365 participants
OBSERVATIONAL
2013-08-31
2022-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mobile Health Platform for Surveillance of Kidney Stone
NCT05389982
Use of an Herbal Preparation to Prevent and Dissolve Kidney Stones
NCT00381849
Evaluation of Pain Before and After Removal of Non-obstructive Kidney Stones
NCT03657667
Evaluating the Vitamin K2 Status of Calcium-based Stone Formers
NCT05081960
Randall's Plaque Study: Pathogenesis and Relationship to Nephrolithiasis
NCT00169806
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Primary Hyperoxaluria
All rare kidney stone patients enrolled in RKSC registries that are able to communicate using the English language, are able to consent to participation in the study, have internet access with an email account and/or a valid address and are at minimum 5 years of age (for SF-10)
Health-related Quality of Life in Rare Kidney Stone Questionnaire
Cystinuria
All rare kidney stone patients enrolled in RKSC registries that are able to communicate using the English language, are able to consent to participation in the study, have internet access with an email account and/or a valid address and are at minimum 5 years of age (for SF-10)
Health-related Quality of Life in Rare Kidney Stone Questionnaire
Dent Disease
All rare kidney stone patients enrolled in RKSC registries that are able to communicate using the English language, are able to consent to participation in the study, have internet access with an email account and/or a valid address and are at minimum 5 years of age (for SF-10)
Health-related Quality of Life in Rare Kidney Stone Questionnaire
APRT deficiency
All rare kidney stone patients enrolled in RKSC registries that are able to communicate using the English language, are able to consent to participation in the study, have internet access with an email account and/or a valid address and are at minimum 5 years of age (for SF-10)
Health-related Quality of Life in Rare Kidney Stone Questionnaire
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Health-related Quality of Life in Rare Kidney Stone Questionnaire
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Be at least 5 years old (for SF-10)
* Are able to communicate using the English language
* Consent to participate in the study (or "assent" if under 18 years old)
* Have internet access with an email account or a valid home address
5 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
NYU Langone Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David Goldfarb, MD
Role: PRINCIPAL_INVESTIGATOR
NYU Langone Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Primary Hyperoxaluria and Dent Disease Registry - Mayo Clinic
Rochester, Minnesota, United States
New York University School of Medicine - Cystinuria Registry
New York, New York, United States
APRT Registry - Landspitali Universtiy Hospital
Reykjavik, , Iceland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Modersitzki F, Pizzi L, Grasso M, Goldfarb DS. Health-related quality of life (HRQoL) in cystine compared with non-cystine stone formers. Urolithiasis. 2014 Feb;42(1):53-60. doi: 10.1007/s00240-013-0621-4. Epub 2013 Nov 20.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
13-00968
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.